Adir Et Compagnie

Adrian Newman-Tancredi

Mark Millan

Jean-Louis Peglion

Bertrand Goument

Aimee Dessinges

Alain Gobert

Gilbert Lavielle

Alex Cordi

Anne Dekeyne

Thierry Dubuffet

Mauricette Brocco

Pierre Renard

Jean-Christophe P Harmange

Daniel Lesieur

Daniel-Henri Caignard

Patrick Depreux

Jean-Michel Lacoste

Marie-Claire Rettori

Pascal Carato

Jean-Paul Bonte

The invention relates to a compound of formula (I):

Spiro imidazoline compounds

A compound selected from those of formula (I): ##STR1## wherein: R.sub.1, R.sub.2, R.sub.3 and R.sub.4, which may be identical or different, represent hydrogen, halogen, alkyl, alkenyl, alkynyl, hydroxy, alkoxy, trihaloalkyl, or any pair may form a heterocycle,

Indan-1-ol compounds

The invention relates to a compound of formula (I): ##STR1## wherein: A represents an optionally substituted benzene ring,

Imidazoline compounds

A compound of formula (I): ##STR1## wherein: Z.sub.1, Z.sub.2, Z.sub.3, Z.sub.4, which may be identical or different, represent a group as defined in the description,

Benzocyclobutane compounds

A compound of formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, X--Y, A, Z and Z' are as defined in the description, in the form of the cis or trans isomers each in racemic or optically active form, and acid addition salts thereof, and medicinal products containing the same are useful in the treatment of diseases of the central nervous system or of manifestations of pain.

Indanol compounds

A compound of formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, X-Y, A, Z and Z' are as defined in the description, in the form of the cis or trans isomers each in racemic or optically active form, and acid addition salts thereof, and medicinal products containing the same are useful in the treatment of diseases of the central nervous system or of manifestations of pain.

A compound of general formula (I): ##STR1## where A, X, R.sub.1, Y, n and Ar are defined in the description. Medicinal products containing the same are useful as D.sub.4 receptor Ligands.

Heterocyclic aminomethyl compounds

A compound selected from those of formula: ##STR1## wherein: A--B, n, D and E are as defined in the specification, their racemic mixtures, and their optical isomers, and also the physiologically tolerable salts thereof with appropriate acids. The products of the invention may be used therapeutically.

Piperazine compounds

Compounds of formula (I): ##STR1## in which: n represents 1 or 2,

Benzopyran compounds as 5-HT.sub.2C receptor antagonists

A compound selected from those of formula: ##STR1## wherein: A-B, n, D and E are as defined in the specification,

Growing community of inventors

le Pecq, France

Adrian Newman-Tancredi